North America Respiratory Inhalers Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Respiratory Inhalers Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Respiratory Inhalers Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Respiratory Inhalers Market Regional Analysis

6.2 North America Respiratory Inhalers Market Revenue 2020-2028 (US$ Million)

6.3 North America Respiratory Inhalers Market Forecast Analysis

7. North America Respiratory Inhalers Market Analysis – by Product Type

7.1 Nebulizers

7.1.1 Overview
7.1.2 Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Metered Dose Inhalers

7.2.1 Overview
7.2.2 Metered Dose Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Dry Powder Inhalers

7.3.1 Overview
7.3.2 Dry Powder Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Respiratory Inhalers Market Analysis – by Technology

8.1 Manually Operated Inhalers and Digitally Operated Inhalers

8.1.1 Overview
8.1.2 Manually Operated Inhalers and Digitally Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Respiratory Inhalers Market Analysis – by Disease Indication

9.1 Asthma

9.1.1 Overview
9.1.2 Asthma: North America Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 COPD

9.2.1 Overview
9.2.2 COPD: North America Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Pulmonary Arterial Hypertension

9.3.1 Overview
9.3.2 Pulmonary Arterial Hypertension: North America Respiratory Inhalers Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Respiratory Inhalers Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Respiratory Inhalers Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America Respiratory Inhalers Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Respiratory Inhalers Market Breakdown, by Product Type
10.2.1.1.2 US: North America Respiratory Inhalers Market Breakdown, by Technology
10.2.1.1.3 US: North America Respiratory Inhalers Market Breakdown, by Disease Indication

10.2.1.2 Canada: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Respiratory Inhalers Market Breakdown, by Product Type
10.2.1.2.2 Canada: North America Respiratory Inhalers Market Breakdown, by Technology
10.2.1.2.3 Canada: North America Respiratory Inhalers Market Breakdown, by Disease Indication

10.2.1.3 Mexico : North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Respiratory Inhalers Market Breakdown, by Product Type
10.2.1.3.2 Mexico : North America Respiratory Inhalers Market Breakdown, by Technology
10.2.1.3.3 Mexico : North America Respiratory Inhalers Market Breakdown, by Disease Indication

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 AstraZeneca Plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Beximco Pharmaceuticals Ltd.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Boehringer Ingelheim International GmbH

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Cipla Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 GSK Plc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Koninklijke Philips NV

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 OMRON Corp

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 OPKO Health, Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 PARI Respiratory Equipment, Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Teva Pharmaceutical Industries Ltd

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Respiratory Inhalers Market

Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)